BrosMed Medical Co., Ltd. Announces CE Mark Approval of the Tri-Wedge PTA Scoring Balloon Dilatation Catheter
Release time:
2020-01-19
February 19th, 2020—BrosMed Medical Co., Ltd. announced CE Mark and launched its Tri-Wedge PTA Balloon Catheter. Tri-Wedge is a Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Dilatation Catheter, which ideal for Arteriovenous Fistula (AV) Shunt Scoring.
February 19th, 2020—BrosMed Medical Co., Ltd. announced CE Mark and launched its Tri-Wedge PTA Balloon Catheter. Tri-Wedge is a Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Dilatation Catheter, which ideal for Arteriovenous Fistula (AV) Shunt Scoring.
Tri-Wedge PTA Scoring Balloon Dilatation Catheter achieves accurate annular fibrous, calcified plaque location and minimal balloon slippage. This balloon with trimetallic wires can reach lesions smoothly with an uniform vertical distribution. High efficient vertical extrusion to score the plaque with concentrated dilatation stress, low pressure and high safety dilatation reduces the vessel wall injury and incidence of restenosis.
“Tri-Wedge Peripheral balloon provides excellent crossing ability, high pressure and non-compliance. It was ideally designed in the treatment of complex lesions with significant calcification and fibrosis. It is believed this unique balloon design technology will make a difference to the PTA scoring balloon market.” said by Stephen Lee, Sr. vice president of BrosMed Medical Co., Ltd. “By continuously improving our balloon performance, we support physicians solving the complex lesions cases”
For more product details and information, please contact your regional distributor and/or our direct sales force at sales@brosmed.com / cs@brosmed.com or +86 769 22892018 / +31 850 140901.
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
BrosMed Medical product portfolio consist of, Artimes™ PTCA, Apollo™ PTCA, Atropos™ 0.035 PTA, Minerva™ 0.018 PTA, Polux™ 0.014 PTA, Hermes™ NC 0.035 PTA, Achilles™ NC 0.018 PTA, Castor™ NC 0.014 PTA, Conger™ Hydrophilic coated wire and series of accessories. NC
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27